NCT03390504 2026-04-13
THOR
Janssen Research & Development, LLC
Phase 3 Active not recruiting
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
Astellas Pharma Inc
Gilead Sciences
Pierre Fabre Medicament
Merck Sharp & Dohme LLC
Pierre Fabre Medicament
Hoffmann-La Roche
Pierre Fabre Medicament
Pierre Fabre Medicament
Bristol-Myers Squibb